APPLICATION
NDA209607
TYPE
NDA
ORIGINAL APPROVAL
2018-07-30
LATEST ACTION
2023-02-14
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
AZEDRA · ReferenceDiscontinued
IOBENGUANE I-131 15mCi/ML · SOLUTION · INTRAVENOUS
Approval history
2019-07-24Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.